ATE175422T1 - Schweineadipozytenantigene und ihre verwendung zur immunologischen kontrolle von fett - Google Patents
Schweineadipozytenantigene und ihre verwendung zur immunologischen kontrolle von fettInfo
- Publication number
- ATE175422T1 ATE175422T1 AT92919644T AT92919644T ATE175422T1 AT E175422 T1 ATE175422 T1 AT E175422T1 AT 92919644 T AT92919644 T AT 92919644T AT 92919644 T AT92919644 T AT 92919644T AT E175422 T1 ATE175422 T1 AT E175422T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- fat
- porcine
- adipocyte
- swine
- Prior art date
Links
- 210000001789 adipocyte Anatomy 0.000 title abstract 2
- 241000282898 Sus scrofa Species 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 230000001900 immune effect Effects 0.000 title 1
- 241000282887 Suidae Species 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 210000000170 cell membrane Anatomy 0.000 abstract 1
- 210000003743 erythrocyte Anatomy 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 210000004165 myocardium Anatomy 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 210000002027 skeletal muscle Anatomy 0.000 abstract 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 abstract 1
- 210000000636 white adipocyte Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919120037A GB9120037D0 (en) | 1991-09-19 | 1991-09-19 | Immunological control of fat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE175422T1 true ATE175422T1 (de) | 1999-01-15 |
Family
ID=10701677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92919644T ATE175422T1 (de) | 1991-09-19 | 1992-09-18 | Schweineadipozytenantigene und ihre verwendung zur immunologischen kontrolle von fett |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5631009A (de) |
| EP (1) | EP0597043B1 (de) |
| JP (1) | JPH06510780A (de) |
| AT (1) | ATE175422T1 (de) |
| AU (1) | AU664147B2 (de) |
| CA (1) | CA2116033A1 (de) |
| DE (1) | DE69228121T2 (de) |
| DK (1) | DK0597043T3 (de) |
| GB (2) | GB9120037D0 (de) |
| NZ (1) | NZ244349A (de) |
| WO (1) | WO1993006131A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001027279A1 (en) * | 1999-10-12 | 2001-04-19 | Cambridge Antibody Technology | Human anti-adipocyte monoclonal antibodies and their use |
| GB2389362B (en) * | 2002-06-05 | 2006-02-15 | Walcom Animal Science | Antibodies to adipose tissues |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5102658A (en) * | 1985-07-19 | 1992-04-07 | National Research Development Corporation | Antibody treatment for adiposity |
| US5096706A (en) * | 1986-03-25 | 1992-03-17 | National Research Development Corporation | Antigen-based treatment for adiposity |
-
1991
- 1991-09-19 GB GB919120037A patent/GB9120037D0/en active Pending
-
1992
- 1992-09-15 NZ NZ244349A patent/NZ244349A/en unknown
- 1992-09-18 EP EP92919644A patent/EP0597043B1/de not_active Expired - Lifetime
- 1992-09-18 AT AT92919644T patent/ATE175422T1/de not_active IP Right Cessation
- 1992-09-18 CA CA002116033A patent/CA2116033A1/en not_active Abandoned
- 1992-09-18 JP JP5505913A patent/JPH06510780A/ja active Pending
- 1992-09-18 DK DK92919644T patent/DK0597043T3/da active
- 1992-09-18 AU AU25686/92A patent/AU664147B2/en not_active Ceased
- 1992-09-18 WO PCT/GB1992/001721 patent/WO1993006131A1/en active IP Right Grant
- 1992-09-18 GB GB9219815A patent/GB2259706B/en not_active Expired - Fee Related
- 1992-09-18 DE DE69228121T patent/DE69228121T2/de not_active Expired - Fee Related
- 1992-09-18 US US08/211,033 patent/US5631009A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| NZ244349A (en) | 1994-10-26 |
| US5631009A (en) | 1997-05-20 |
| GB2259706A (en) | 1993-03-24 |
| WO1993006131A1 (en) | 1993-04-01 |
| EP0597043B1 (de) | 1999-01-07 |
| EP0597043A1 (de) | 1994-05-18 |
| DK0597043T3 (da) | 1999-08-30 |
| CA2116033A1 (en) | 1993-04-01 |
| GB9120037D0 (en) | 1991-11-06 |
| DE69228121T2 (de) | 1999-06-10 |
| JPH06510780A (ja) | 1994-12-01 |
| GB9219815D0 (en) | 1992-10-28 |
| GB2259706B (en) | 1995-07-12 |
| DE69228121D1 (de) | 1999-02-18 |
| AU2568692A (en) | 1993-04-27 |
| AU664147B2 (en) | 1995-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE212378T1 (de) | Stressproteine und ihre verwendung | |
| ATE107958T1 (de) | Herstellung eines insulinähnlichen, wachstümsfaktor bindenden proteins. | |
| DE69509628T2 (de) | N-terminal chemisch modifizierte protein-zusammensetzungen und methoden | |
| DE69316948T2 (de) | Lösliche Liganden für CD40 | |
| DE69329030D1 (de) | Antigen enthaltende mikropartikel und ihre verwendung für die induzierung von humoralen oder zellulären antworten | |
| DE69011859D1 (de) | Verwendung von sigma-rezeptor-liganden zur herstellung eines anxiolytikums. | |
| DK0523395T3 (da) | Seroreaktive områder på proteinerne E1 og E2 i HPV 16 | |
| ATE167516T1 (de) | Colostrum fraktion und ihre verwendung als additiv beim zellkulturmedium | |
| DE69518760T2 (de) | Wachstumsdifferenzierungsfaktor-12 | |
| FR2491334B1 (de) | ||
| DE69737651D1 (de) | Cortistatin: neuropeptide, zusammensetzungen und methoden | |
| DE58904713D1 (de) | Verwendung von zink- oder eisenhydroxid zur adjuvierung von antigenloesungen und auf diese weise adjuvierte antigenloesungen. | |
| ATE175422T1 (de) | Schweineadipozytenantigene und ihre verwendung zur immunologischen kontrolle von fett | |
| ITRM920506A1 (it) | Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi. | |
| DE69230881T2 (de) | Corticotropinauslösefaktor-bindendes protein | |
| DE69428272D1 (de) | Lo-cd2a antikörper und dessen verwendung zur inhibition von t-zell-aktivierung und -wachstum | |
| DE69302375D1 (de) | Kosmetische zusammensetzung zur erhaltung der frisur enthaltend ein milchprotein und/oder ein milchproteinhydrolysate und ein hydrolysate | |
| DE59814002D1 (de) | Sekretion von tragergebundenen proteinen in das periplasma und in den extrazellulären raum | |
| DE3570677D1 (en) | Acino-foetal differentiation proteins associated with cancer of the pancreas, antiserum and monoclonal antibodies against these proteins and processes for their preparation | |
| SE9604439D0 (sv) | New receptor | |
| RU94026276A (ru) | Рецепторы интерлейкина-12 и антител |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |